Join the 'Bimatoprost' group to help and get support from people like you. How it works
Summary
Latest Blog Post
Allergan, Inc. Receives FDA Approval for Lumigan 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients
IRVINE, Calif.--(BUSINESS WIRE)--Aug 31, 2010 - Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved Lumigan (bimatoprost ophthalmic solution) 0.01% as a ...
Further Information
Related Condition Support Groups
Glaucoma (Open Angle), Intraocular Hypertension
